Document is current
Any future updates will be listed below
-
Authors
Brand, Yonatan E.
Kluge, Felix
Palmerini, Luca
Paraschiv-Ionescu, Anisoara
Becker, Clemens
Cereatti, Andrea
Maetzler, Walter
Sharrack, Basil
Vereijken, Beatrix
Yarnall, Alison J.
Rochester, Lynn
Del Din, Silvia
Muller, Arne
Buchman, Aron S.
Hausdorff, Jeffrey M.
Perlman, Or
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01AG017917, R01AG056352, R01AG79133, R01AT012228)
Innovative Medicines Initiative (820820)
- License Information
-
More Information
Article History
Received: 14 March 2024
Accepted: 28 August 2024
First Online: 6 September 2024
Competing interests
: A. Mueller and F. Kluge are employees of and may hold stock in Novartis. L. Palmerini is co-founder and own share of mHealth Technologies (). C. Becker are consultants of Philipps Healthcare, Bosch Healthcare, Eli Lilly, Gait-up. S. Del Din and J. Hausdorff report consultancy activity with Hoffmann-La Roche Ltd. outside of this study. The other authors have no competing interests.
: For the Rush Memory and Aging project, all participants provided written informed consent before participation. The study was approved by the Rush University Medical Center Institutional Review Board and conducted in accordance with the Declaration of Helsinki. For the Mobilise-D study, ethical approval was obtained at the individual sites (London-Bloomsbury Research Ethics Committee, 19/LO/1507; Helsinki Committee, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 0551-19TLV; ethical committee of the medical faculty of The University of Tübingen, 647/2019BO2; ethical committee of the medical faculty of Kiel University, D438/18) and all participants gave informed consent before participating.
